Literature DB >> 29894151

DARK Classics in Chemical Neuroscience: Fentanyl.

S Mallory Burns1, Christopher W Cunningham2, Susan L Mercer1,3.   

Abstract

Fentanyl rose to prominence as an alternative analgesic to morphine nearly 50 years ago; today, fentanyl has re-emerged as a dangerous recreational substance. The increased potency and analgesic effect of fentanyl are advantageous in the treatment of pain but are also responsible for the rise in unintentional opioid overdose deaths. In response to this crisis, fentanyl, its analogues, and even precursors are under heightened regulatory scrutiny. Despite this controversial history, derivatization of fentanyl has resulted in numerous synthetic analogues that provide valuable insights into opioid receptor binding and signaling events. In this review, the impact of fentanyl on chemical neuroscience is shown through its synthesis and properties, manufacturing, metabolism, pharmacology, approved and off-label indications, adverse effects, and the responsibility it has in the opioid epidemic.

Entities:  

Keywords:  Fentanyl; analgesic; designer drug; opioid; pain

Mesh:

Substances:

Year:  2018        PMID: 29894151     DOI: 10.1021/acschemneuro.8b00174

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  17 in total

1.  Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose.

Authors:  Philip Krieter; Shwe Gyaw; Roger Crystal; Phil Skolnick
Journal:  J Pharmacol Exp Ther       Date:  2019-04-02       Impact factor: 4.030

2.  Affinity of fentanyl and its derivatives for the σ1-receptor.

Authors:  Piotr F J Lipiński; Edina Szűcs; Małgorzata Jarończyk; Piotr Kosson; Sándor Benyhe; Aleksandra Misicka; Ján Cz Dobrowolski; Joanna Sadlej
Journal:  Medchemcomm       Date:  2019-06-13       Impact factor: 3.597

3.  Covalently Loaded Naloxone Nanoparticles as a Long-Acting Medical Countermeasure to Opioid Poisoning.

Authors:  Andrew J Kassick; Mariah Wu; Diego Luengas; Mohammad Ebqa'ai; L P Tharika Nirmani; Nestor Tomycz; Toby L Nelson; Marco Pravetoni; Michael D Raleigh; Saadyah Averick
Journal:  ACS Pharmacol Transl Sci       Date:  2021-08-26

4.  Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose.

Authors:  Philip Krieter; Shwe Gyaw; C Nora Chiang; Roger Crystal; Phil Skolnick
Journal:  J Clin Pharmacol       Date:  2019-01-30       Impact factor: 3.126

5.  Opioid moderatism and the imperative of rapprochement in pain medicine.

Authors:  Michael E Schatman; Alexis Vasciannie; Ronald J Kulich
Journal:  J Pain Res       Date:  2019-02-12       Impact factor: 3.133

Review 6.  Essential pharmacologic options for acute pain management in the emergency setting.

Authors:  David H Cisewski; Sergey M Motov
Journal:  Turk J Emerg Med       Date:  2018-12-10

7.  Higher doses of naloxone are needed in the synthetic opiod era.

Authors:  Ronald B Moss; Dennis J Carlo
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-02-18

8.  Peripheral antinociceptive effects of a bifunctional μ and δ opioid receptor ligand in rat model of inflammatory bladder pain.

Authors:  Maia Terashvili; Bhavana Talluri; Watchareepohn Palangmonthip; Kenneth A Iczkowski; Patrick Sanvanson; Bidyut K Medda; Banani Banerjee; Christopher W Cunningham; Jyoti N Sengupta
Journal:  Neuropharmacology       Date:  2021-07-10       Impact factor: 5.273

9.  Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level.

Authors:  Ronald B Moss; Meghan McCabe Pryor; Rebecca Baillie; Katherine Kudrycki; Christina Friedrich; Mike Reed; Dennis J Carlo
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240

10.  How mu-Opioid Receptor Recognizes Fentanyl.

Authors:  Quynh Vo; Paween Mahinthichaichan; Jana Shen; Christopher Ellis
Journal:  Res Sq       Date:  2020-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.